Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sangui Biotech International Inc (SGBI) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Sangui Biotech International Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1104280.
Total stock buying since 2021: $0.
Total stock sales since 2021: $24,000.
Total stock option exercises since 2021: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2021 | 0 | $0 | 1,200,000 | $24,000 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2021-10 | 0 | $0 | 1,200,000 | $24,000 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-10-13 | Schmelz Hubertus (Director) | Sale | 1,200,000 | .02 | 24,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of SGBI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Sangui Biotech International Inc (symbol SGBI, CIK number 1104280) see the Securities and Exchange Commission (SEC) website.